(A) Schematic illustration showing the application of DOX/CP-NI NPs for drug delivery.
(B) In vitro drug release from DOX/CP-NI NPs in different conditions.
(C) Pulsatile release profile of DOX/CP-NI NPs at different pH for light/dark cycles.
(D) CLSM images of HeLa cells treated with different formulations.
Reproduced with permission from Qian et al.42 Copyright 2016, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.